Cambrex (CBM) Worth Watching: Stock Soars 27.5% - Tale of the Tape
Cambrex Corporation (CBM) was a big mover last session with its shares surging roughly 28% on the day. The upside was owing to the company’s announcement of its fourth quarter and full year 2014 financial results which exceeded expectations on both lines. This development led to far more shares changing hands yesterday than in a normal session. The move continues the recent uptrend of the company as the stock has gained nearly 41% in the past one-month time frame.
This life sciences company that provides products and services for the development and commercialization of new and generic therapeutics worldwide has seen no estimate revision in the last 30 days. However, the Zacks Consensus Estimate has moved higher over the same period. This implies solid trading potential for the company. So make sure to keep an eye on this stock going forward to see if Friday’s climb can turn into more strength down the road.
Cambrex currently has a Zacks Rank #3 (Hold).
A better-ranked bio-med/gene stock is Affymetrix Inc. (AFFX) with a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
CAMBREX CORP (CBM): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
